The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines (PCV10 and PCV13) on Immunogenicity and Vaccine-serotype Carriage in Kenyan Infants
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2018
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms FPCV
- 29 Nov 2018 New trial record
- 22 Nov 2018 Planned End Date changed from 1 Sep 2020 to 1 May 2021.
- 22 Nov 2018 Planned primary completion date changed from 1 Apr 2020 to 1 Sep 2020.